谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase II Study of Irinotecan and Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer (tohoku Gynecologic Cancer Unit 104 Study).

Tadahiro Shoji,Eriko Takatori,Hideo Omi,Masahiro Kagabu,Tatsuya Honda,Masayuki Futagami,Yoshihito Yokoyama,Michiko Kaiho,Hideki Tokunaga,Takeo Otsuki,Tadao Takano,Nobuo Yaegashi,Takanobu Kojimahara,Tsuyoshi Ohta,Satoru Nagase,Shu Soeda, Takafumi Watanebe,Hiroshi Nishiyama,Toru Sugiyama

Cancer chemotherapy and pharmacology（2017）

引用 10|浏览4
暂无评分
关键词
Recurrent ovarian cancer,Chemotherapy,CPT-11,PLD
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要